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Cardiac arrest can occur following a myriad of clinical conditions. With advancement of
medical science and improvements in Emergency Medical Services systems, the rate of
return of spontaneous circulation for patients who suffer an out-of-hospital cardiac arrest
(OHCA) continues to increase. Managing these patients is challenging and requires a
structured approach including stabilization of cardiopulmonary status, early consideration
of neuroprotective strategies, identifying and managing the etiology of arrest and initiating
treatment to prevent recurrence. This requires a closely coordinated multidisciplinary
team effort. In this article, we will review the initial management of survivors of OHCA,
highlighting advances and ongoing controversies.
Copyright ª 2014, Cardiological Society of India. All rights reserved.1. Introduction
Cardiac arrest (CA) is often the terminal event following pro-
gression of and decompensation from a wide range of path-
ophysiological events. With medical advances and
improvements in the delivery of prehospital care, we are
witnessing increasing rates of return of spontaneous circula-
tion (ROSC) following CA. Once resuscitated, the next chal-
lenge is to manage these patients appropriately so as to not
only prevent mortality but preserve neurological andm Jackson Park Road, Po
pta).
2014, Cardiological Societcognitive function. Proper post-resuscitation care (PRC) has
been shown to reduce mortality and morbidity.1e3 To achieve
this, a closely coordinated multidisciplinary team effort is
required. The key steps involved in caring for these patients
include:
- Assessment and stabilization of cardiopulmonary status
- Determining etiology of arrest
- Neuroprotection
- Preventing recurrence of arrest.rtland, OR 97239-3098, USA.
y of India. All rights reserved.
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the patient regains a pulse. A schematic overview ofmanaging
patients post-ROSC is outlined in Fig. 1.2. Prehospital management
After ROSC, (defined as a palpable pulse and recordable blood
pressure and if monitored, increase in ETCO2 of >40 mm of
Hg), emergency medical services (EMS) personnel should
transport patients to facilities equipped with managing the
complex needs of these patients. It may be safe to bypass
closer medical facilities and transport patients to institutions
capable of meeting the needs for PRC.4e6 Prior to and during
transport, intravenous access should be established and cir-
culation, airway and breathing (CAB) supported in accordance
with basic and advanced cardiac life support guidelines. If
possible, a 12-lead electrocardiogram (ECG) should be ob-
tained. If the field ECG is consistent with a ST-segment
elevation myocardial infarction (STEMI), the cardiac cathe-
terization team at the receiving facility should be alerted.
Although some EMS systems currently initiate therapeutic
hypothermia (TH) for neuroprotection in patients who remain
comatose post-ROSC, there is lack of conclusive evidence of
improvements in outcomes when compared to delayed initi-
ation of hypothermia in the ED.7 Until, further evidence be-
comes available, the strategy of prehospital post-resuscitation
hypothermia cannot be routinely recommended.3. Emergency Department (ED) management
Initial management of patients post-ROSC involves a multi-
system approach8 and should focus on several key areas
simultaneously:
- Adequate ventilation and oxygenation
- Hemodynamic optimization
- Cardiovascular stabilization
- Management of metabolic derangements
- Determining the etiology and initiating treatment of the
etiology of arrest
- Neurological assessment and consideration of therapeutic
hypothermia.
Upon arrival in ED, patient’s cardiopulmonary and neuro-
logical status should be promptly assessed. Continuous car-
diac monitoring, pulse oximetry, capnography and NIBP (non-
invasive blood pressure) monitoring should be initiated. This
provides critical information on tissue oxygenation and
perfusion and helps guide further resuscitative care.
A brief and focused history should be obtained if feasible.
Since most patients may be unable to communicate, this may
need to be obtained from EMS personnel, family, friends or
bystanders who have witnessed the arrest. Up to 80% of pa-
tients have symptoms preceding the arrest.9 Historical evi-
dence of chest pain, shortness of breath, palpitations, light
headedness, abdominal pain, back pain, recent infection, loss
of postural tone, focal neurological deficits, seizures, and ev-
idence of trauma or bleeding may provide clues to specificetiologies. Information should also be obtained about past
medical history, recent travel, medications, known allergies
and whether patients were eating at the time of arrest.
A focused physical examination should be performed in
the ED. Pupils should be checked for size, symmetry and
response to light. Lungs should be assessed for ventilation
adequacy. Stridor and wheezing may point to underlying
upper or lower airway obstruction and asymmetric breath
sounds should raise concern for an associated pneumothorax
(PTX). Cardiac examination should focus on identifying dys-
rhythmias, adequacy of circulation assessed by blood pres-
sure and pulse strength in all 4 limbs. Presence of cardiac
murmurs should be noted. Low intensity or distant heart
sounds should prompt consideration for underlying pericar-
dial tamponade. Abdomen should be assessed for evidence of
distension, guarding or presence of pulsatile masses. Rectal
exam should be considered to evaluate for gastrointestinal
bleeding. The patient should also be assessed for complica-
tions related to cardiopulmonary resuscitation (CPR).
All patients presenting with ROSC should undergo a thor-
ough and detailed neurological exam to evaluate mental sta-
tus (using a validated scale such as the Glasgow Coma Score
(GCS)) and identify focal neurological findings. Patients who
remain comatose (unable to follow verbal commands or a GCS
of 8) and whose first recorded rhythm was ventricular
fibrillation (VF) benefit from Therapeutic Hypothermia (TH)
and this should be initiated as soon as feasible.10,11
3.1. Initial workup
The workup should focus on assessing organ function and
identifying underlying causes (Table 1).
- A basic metabolic panel including a magnesium level can
identify electrolyte abnormalities,12 a complete blood
count with differential may aid in identifying infection or
anemia. An arterial blood gas (ABG) permits assessment for
acidosis, hypoxia and hypercapnea while providing feed-
back on ventilatory status. Serum lactate levels are helpful
to assess tissue perfusion. Resuscitated patients with
elevated lactate levels require serial measurements;
greater lactate clearance at 24 h is associated with
improved survival.13 Baseline coagulation tests and cardiac
biomarkers (troponin, CPK-MB) may be obtained and seri-
ally followed as needed though the utility of initial
troponin levels in directing initial management of patients
post-ROSC remains unclear.14 Toxicology testing can be
considered in selected cases, although results rarely
change initial management. When available, point-of-care
testing should be utilized to expedite clinical decision
making.
- A 12-lead ECG should be analyzed in all patients with CA
for presence of ST-segment deviation, T-wave abnormal-
ities, dysrhythmias, conduction defects, QT-interval and
presence of low voltage (which may indicate tamponade).8
An initial as well as repeat 12-lead ECG’s are critical for
early recognition of ongoing myocardial ischemia and
presence of arrhythmias that require treatment. A 64-lead
continuous ST mapping obtained using a chest vest may
enhance sensitivity and specificity compared to a standard
Fig. 1 eAlgorithm highlighting the important pathways involved in caring for patient with ROSC post-cardiac arrest. ROSC e
return of spontaneous circulation; CAB e circulation, airway, breathing; ECG e electrocardiogram; iv e intravenous, SBP e
systolic blood pressure; MAP e mean arterial pressure; PCI e percutaneous coronary intervention; ET e endotracheal; K e
potassium; Ed e Emergency Department, ICU e intensive care unit. * Can keep FIO2 of 100% in case of carbon monoxide or
cyanide poisoning.
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Table 1 e Common causes of cardiac arrest.
Cardiovascular
causes
Acute coronary syndromes
Arrhythmias
Structural heart disease: Hypertrophic
cardiomyopathy, ARVD
Cardiac tamponade
Aortic dissection or aortic aneurysm rupture
Blunt cardiac trauma: commotio cordis
Pulmonary
causes
Pulmonary embolism
Status asthmaticus
Airway obstruction : foreign body, mucus
plugging
Pneumothorax
Hypoxia
Electrolyte
abnormalities
Hypokalemia/hyperkalemia
Hypomagnesemia
Hypocalcemia/hypercalcemia
Acidosis
Renal failure
Infection Sepsis
Hypovolemia Bleeding
Gastrointestinal losses
Diuretic therapy
Toxins Cocaine abuse
Amphetamines
Opiate overdose
Cardio active agents
Benzodiazepine overdose
Tricyclic antidepressants
ARVD e arrhythmogenic right ventricular dysplasia.
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clusion,15 however, additional studies are warranted prior
to recommending routine implementation of this strategy.
- Imaging studies:
 Chest X-Ray (CXR): A portable CXR can identify pulmo-
nary etiologies or complications such as pulmonary
edema, PTX, pneumonia and verify correct positioning of
endotracheal tube patients who are intubated.
 CT: In comatose patients, non-contrast CT of brain may
help in early detection of underlying stroke as well as
cerebral edema. The presence of cerebral edema on CT
post-CA is associated with decreased survival.16 A CT of
abdomen and pelvis should be considered in patients
with suspected abdominal etiology. A contrast chest CT
is helpful in the workup for suspected pulmonary em-
bolism (PE) or aortic dissection.
 Echocardiography and Ultrasonography (US): Bedside
echocardiography can be performed if there is suspicion
of underlying cardiac ischemia and the initial ECG is non-
diagnostic. Global hypokinesis is expected but regional
wall motion abnormalities suggest ischemia. In patients
with suspected PE who cannot undergo CT, echocardio-
graphic evidence of right ventricular dysfunction or in
some instances direct visualization of clot can confirm
the diagnosis. Pericardial tamponade and structural
heart diseases such as hypertrophic cardiomyopathy can
also be identified rapidly through bedside echocardiog-
raphy. In addition, US can be used to assess for presence
of PTX, pulmonary edema, intra-abdominal bleeding,
and volume status based on the size of inferior vena
cava.17 Electroencephalogram (EEG): Status epilepticus can lead
to CA and non-convulsive status epilepticus (NCSE) is
often seen post-arrest.18 Continuous EEG has a high
sensitivity for detecting this and should be performed as
soon as feasible in comatose patients.8 Patients under-
going TH should have continuous EEG monitoring to
detect seizures and to help differentiate seizures from
hypothermia induced shivering.
3.2. Ventilation
Following resuscitation, the airway should be assessed to
ensure adequate oxygenation and ventilation in all patients. A
safe airway should be established and comatose patients
intubated (if not done prior to arrival). Mechanical ventilator
settings should be adjusted as needed based on ABG results.
Patients who develop ARDS should be managed with low tidal
volume ventilation with PEEP adjusted to keep plateau pres-
sures 30 cm of H2O.21
Awake patients with appropriate respiratory effort and
able to maintain their airway can be monitored without
intubation. Controlled use of supplemental oxygen to achieve
SpO2 94% is recommended in the non-intubated patients
post-resuscitation. Similarly, in patients who are intubated
FIO2 should be quickly titrated to maintain SpO2 94%. Higher
PaO2 levels may lead to adverse neurological outcomes sec-
ondary to generation of free radicals and brain lipid peroxi-
dation in the context of global ischemia followed by
reperfusion.8,19
PaCO2 should also be kept in normal range. Hyperventila-
tion can lead to decrease in PaCO2, and decrease cerebral
perfusion leading to worsening of post-ischemic cerebral
injury.20 Additionally, hyperventilation decreases expiratory
time leading to air trapping and increase in intrathoracic
pressure. This impedes preload and decreases cardiac output
which can be deleterious in hypotensive patients. Generally,
PaCO2 should be maintained around 40e45 mm of Hg and, if
monitored, end-tidal CO2 (capnometry) level should be kept
between 35e40 mm of Hg.8
3.3. Hemodynamic optimization
Post-CA, it is essential to maintain perfusion to vital organs to
prevent further clinical deterioration. Irrespective of the eti-
ology of arrest, there may be temporary myocardial dysfunc-
tion and inability tomaintain adequate cardiac output.22,23 For
optimal organ perfusion a MAP (mean arterial pressure)
65 mm of Hg should be targeted. The first step in ensuring
this is adequate volume resuscitation with isotonic fluids
(0.9% normal saline or ringer’s lactate) to achieve a central
venous pressure of 8e12 cm of H2O. Cold saline may be used
for volume loading if TH is being considered. If, after adequate
volume supplementation (usually 2e3 L of isotonic fluids), the
MAP remains <60e65 mm of Hg; vasopressors and inotropic
agents should be added. The available agents include
norepinephrine, dopamine, epinephrine, phenylephrine,
dobutamine and milrinone. There is paucity of data to defin-
itively recommend one agent and choice of agents should be
dictated by goals of therapy, side effects and familiarity of
providers. While optimization is underway, hemodynamic
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NIBP monitoring or, in some instances invasive direct arterial
pressure monitoring.
3.4. Cardiovascular stabilization and role of coronary
angiography
Coronary artery occlusion remains a leading cause of out-of-
hospital cardiac arrest (OHCA).24,25 An initial 12-lead ECG
should be obtained in all patients post-arrest.8 If STEMI is
noted, reperfusion therapy should be strongly considered:
either via primary percutaneous coronary intervention (PCI)
or intravenous fibrinolytic therapy as both have been shown
to be efficacious.26 Traumatic or prolonged CPR (>10 min) is a
relative contraindication to fibrinolytic use27 and the risk and
benefits of fibrinolysis should be considered in this sub-group.
PCI can be safely performed in patients undergoing TH28 but
the safety of fibrinolytic therapy for STEMI in conjunctionwith
TH is less well established. Preliminary studies suggest that
the risk of stent thrombosis is no different in patients treated
with or without TH.29 Consideration may be given to per-
forming angiography (and possible PCI) in all patients
following ROSC who do not have an alternate explanation of
arrest irrespective of the ECG findings30,31 but the benefit of
routinely implementing this approach remains controversial
and it has been challenging to identify patients who would
benefit most from invasive assessment and treatment. Future
research should be directed towards developing modalities
identifying these patients appropriately. Body surface poten-
tial mapping as mentioned previously is one such modality.15
Continuous cardiac monitoring should be performed in all
patients to monitor for arrhythmias in the post-arrest period.
When detected, arrhythmias should be managed as appro-
priate per current resuscitation guidelines.8 Patients with MI
who continue to be hypotensive despite revascularization
may need mechanical augmentation with devices such as
intra-aortic balloon pump or percutaneous mechanical cir-
culatory support in addition to vasoactive agents and fluids
provided no contraindications exist.
3.5. Therapeutic hypothermia
Neurological injury is a major cause of death following suc-
cessful resuscitation.32 Post-resuscitation TH has been
demonstrated to improve neurological outcomes in comatose
patients whose initial recorded rhythm was VF.10,11 Harmful
pathways that accompany reperfusion injury seem to be
inhibited by hypothermia and exacerbated by hyperthermia.
According to the 2010 AHA guidelines,8 all comatose patients
with ROSC after out of hospital VF arrest should be cooled to
32 Ce34 C for 12e24 h. TH should be considered for coma-
tose patients with ROSC after in-hospital CA from any rhythm
or OHCA from PEA or Asystole. Active rewarming is contra-
indicated in patients who develop spontaneous hypothermia
(temperature >32 C) after ROSC post-CA within the first 48 h.
TH should be induced as soon as possible, preferably
within 6 h of CA based on animal studies. TH can be induced
using cold saline infusion,7 endovascular33 or surface cooling
devices.34 Unintentional overcooling should be avoided. All
hospitals should establish standardized protocols forinitiation and management of TH based on local logistics and
staff training.
During initiation and maintenance of TH, core body tem-
perature should be monitored continuously using esophageal
probe, bladder temperature catheter in non-anuric patients or
central venous probe.10,11 Axillary, oral, tympanic and rectal
temperatures can differ from core body temperature and
should be avoided.8 Shivering has an adverse impact on
maintenance of hypothermia and patients should be sedated
and if needed administered paralytics to avoid this compli-
cation of TH.
Important complications of TH include increased suscep-
tibility to infections,11,35 bleeding,34 electrolyte depletion,
bradyarrhythmias and hyperglycemia.36 Appropriate pre-
cautions should be taken to prevent infections and when
appropriate, antibiotics initiated. Frequent electrolyte moni-
toring should be performed during TH37 and appropriate he-
modynamic support maintained. Insulin therapy may be
required to prevent hyperglycemia.
Rewarming post-TH should be gradual and not exceed
0.5 C/h as rapid rewarming can lead to cerebral edema,
hyperkalemia and seizures.3.6. Glycemic control
Unless hypoglycemia is the cause of arrest, post-arrest pa-
tients usually demonstrate hyperglycemia. Hyperglycemia is
detrimental38 and impairs neurological recovery.39 Optimal
blood glucose range in patients post-CA remains unknown but
strict normoglycemia is not required.40 Strict blood sugar
control with intensive insulin therapy targeting values lower
than 110 mg/dl can lead to hypoglycemia41 which has been
associated with increased mortality.42 Additionally, strict
glucose control compared with moderate glucose control has
not been shown to confer any mortality benefit in these pa-
tients.43 Thus, moderate glycemic control (144e180 mg/dl) is
preferred and insulin therapy should be targeted to this goal.83.7. Management of specific etiology of arrest
Table 2 briefly summarizes management of common etiol-
ogies of CA.4. Neuroprognostication
Neuroprognostication in patients post-CA is clinically chal-
lenging. While it’s important to guide medical decision mak-
ing regarding withdrawal of care, no single test reliably
predicts poor outcomes, especially in the first 24 h post-ar-
rest.8 Generally, multiple independent prognosticators should
be used to assess the severity of neurological damage.44 Prior
to attempting neuroprognostication, any potential con-
founding factors such as hypotension, seizures, toxins or
neuromuscular blockers should be excluded. The exact timing
of neuroprognostication in patients who have undergone TH
remains unknown.45 According to 2010 AHA recommenda-
tion, all neuroprognostication efforts should be avoided in the
first 72-h post-arrest in patients treated with TH.8 In patients
Table 2 e Management of common causes of cardiac
arrest.
Acute coronary
syndrome
Coronary revascularization: PCI/fibrinolytic
therapy
Hypoxia Management of underlying etiology,
supportive mechanical ventilation
(if needed)
Pulmonary
embolism
Anticoagulation, consideration should
be given to fibrinolysis and thrombectomy.
Electrolyte
abnormalities
Hypokalemia: Supplementation
Hyperkalemia: Calcium chloride/calcium
gluconate, sodium bicarbonate, albuterol
nebulizers, sodium polystyrene sulfonate
or diuresis as may be appropriate clinically
Hypomagnesemia: intravenous magnesium
supplementation (always use in hypokalemic
patients)
Acidosis: Reverse underlying cause, consider
bicarbonate for patients with severe metabolic
acidosis
Hypoglycemia: intravenous dextrose
Cardiac
tamponade
Pericardiocentesis
Pneumothorax Needle thoracostomy followed by chest tube
insertion
Anaphylaxis Epinephrine
Toxins Use of antidotes as appropriate.
Anemia/
hypovolemia
Isotonic crystalloid fluids, packed RBCs.
Severe
hypothermia
Gentle rewarming
Stroke Revascularization for ischemic stroke
depending on timing, consideration to
neurosurgical decompression for
hemorrhagic stroke.
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24-h post-arrest.
Findings on neurological exam associated with poor
prognosis in patients not undergoing TH include: absent
corneal reflex at 24 h, absent pupillary reflex at 24 h, absent or
withdrawal response to pain at 24 h and nomotor response at
24 and 72 h.46 In patients undergoing TH, a score of 5 on GCS
motor scale (GCS-M) and normal brain stem reflexes have
been associatedwith favorable prognosiswhile a bilateral lack
of pupillary reflex, corneal reflex and a score of 1e2 on GCS-M
have been associated with unfavorable outcome.44
When available, somatosensory evoked potentials (SSEP)
can be helpful in neuroprognostication. Bilateral absence of
N20 cortical response to median nerve stimulation on SSEP is
associated with poor prognosis.8,44 Results of SSEPs are not
affected by sedation and preliminary results suggest that
SSEPs may be useful in patients undergoing TH.44,47
No EEG finding can reliably predict poor outcome in first
24 h post-arrest.8 In patients not treated with TH, an EEG
showing generalized suppression to <20 mV, burst suppres-
sion pattern associated with generalized epileptic activity or
diffuse periodic complexes on flat background is associated
with poor outcome.8,48 In patients treated with TH, a reactive
or a continuous EEG background after rewarming is associated
with favorable prognosis while burst suppression pattern,
electro-cerebral inactivity or status epilepticus are associated
with unfavorable prognosis.44Findings on neuroimaging are less well defined but loss of
gray whitematter interface and diffuse ischemia on CT or MRI
are associated with poor prognosis.8,44
Biomarkers such as Neuron Specific Enolase and S100-B
have been evaluated for prognostication in patients post-CA.
Elevated levels of these biomarkers have been associated with
poor prognosis but there is variability and lack of standardi-
zation in these studies.44 Sole reliance on biomarkers for
neuroprognostication is not recommended at this time.85. Preventing re-arrest
The most important measure to prevent re-arrest is identi-
fying and treating the etiology of initial arrest. If any further
episodes of CA occur while the patient is being monitored,
then they should be treated with CPR, defibrillation, vaso-
pressors and antiarrhythmic therapy as appropriate. At this
time evidence is insufficient to routinely recommend or refute
using antiarrhythmic agents prophylactically.86. Role of specialized centers
Managing patients post-CA involves a team based approach
and requires complex coordination of care including acute he-
modynamic stabilization, management of mechanical venti-
lation, consideration of THand interventions such as emergent
PCI. These objectives are best achieved at centers having
expertise in dealing with this complex subset of patients. Cen-
ters dealing with larger volume of post-CA patients have been
shown to have superior outcomes5 and lower in-hospital mor-
tality rates.49 Regional centers for care of patients who survive
CA have been proposed by international organizations4 and
there is a need for local regulatory authorities to formulate and
implement an action plan to achieve this goal. CA can unfor-
tunately happen to anyone, and everyone should at-least get
the best possible shot at survival by implementation and utili-
zation of available evidence based therapies.7. Summary
Management of patients following resuscitation from CA is
complex and requires specialized institutions capable of
providing advanced care therapies. Optimal management re-
quires consideration of multiple processes simultaneously. In
addition to CABs of advanced cardiac life support, neuro-
protection with TH should be initiated in comatose patients.
The presence of coronary artery occlusion as a cause of arrest
should be determined through analysis of the 12-lead ECG and
when present, treated expeditiously. Patients should be moni-
tored closely in a critical care setting and neuroprognostication
should be performed no earlier than 24 h in patients not un-
dergoing TH and after 72 h in patients undergoing TH.Conflicts of interest
All authors have none to declare.
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